Ankle-Brachial Index Improves the Classification of Cardiovascular Risk: PERART/ARTPER Study

被引:20
作者
Baena-Diez, Jose M. [1 ,2 ]
Alzamora, Maria T. [3 ,4 ,5 ]
Fores, Rosa [3 ]
Pera, Guillem [5 ]
Toran, Pere [5 ]
Sorribes, Marta [6 ]
机构
[1] Inst Catala Salut, Ctr Salud La Marina, Barcelona, Spain
[2] Inst Catala Salut, Inst Invest Atenc Primaria IDIAP Jordi Gol, Barcelona, Spain
[3] Inst Catala Salut, Ctr Salud Riu Nord Riu Sud, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
[5] Inst Catala Salut, Unitat Recerca Metropolitana Nord, Barcelona, Spain
[6] Inst Catala Salut, Ctr Salad St, Barcelona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2011年 / 64卷 / 03期
关键词
Ankle-brachial index; Coronary heart disease risk functions; Reclassification measures; Peripheral arterial disease; ARTERIAL-DISEASE; PREVENTION; GUIDELINES; MORTALITY; EVENTS; SCORE;
D O I
10.1016/j.recesp.2010.10.024
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction and objectives: The sensitivity of cardiovascular risk functions is low because many cardiovascular events occur in low- or intermediate-risk patients. The aim of the present study was to evaluate how the ankle-brachial index (ABI) reclassifies these patients. Methods: We conducted a descriptive, transversal, multicenter study (28 centers) of 3171 randomly selected patients aged > 49 years. We studied demographic variables, clinical history and cardiovascular risk factors, ABI (defined as pathologic if < 0.9) and 10-year cardiovascular risk with the Framingham-Wilson, REGICOR and SCORE equations, dividing risk into three categories: low (Framingham < 10%, REGICOR < 5% and SCORE < 2.5%, intermediate (10-19.9%, 5-9.9% and 2.5-4.9%, respectively) and high (>= 20%, >= 10% and >= 5%, respectively). Low- or intermediate-risk patients were reclassified as high-risk if they presented ABI <0.9. Results: We compared patients with ABI < 0.9 and patients with ABI >= 0.9 and found the former were significantly older, more frequently men, had a worse history and more cardiovascular risk factors, and included more high-risk patients than when the classification used Framingham-Wilson (42.7% vs. 18.5%), REGICOR (25.8% vs. 9.3%) and SCORE (42.2% vs. 15.9%) equations. In men, using ABI led to a 5.8% increase in the high-risk category versus Framingham-Wilson, a 19.1% increase versus REGICOR and a 4.4% increase versus SCORE. In women, the increases were 78.6% versus Framingham-Wilson, 151.6% versus REGICOR and 50.0% versus SCORE. Conclusions: The ABI reclassifies a substantial proportion of patients towards the high-risk category. This is particularly marked in women and by comparison with REGICOR scores. Full English text available from: www.revespcardiol.org (C) 2010 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 29 条
[1]
Peripheral arterial disease study (PERART): Prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality [J].
Alzamora, Maria Teresa ;
Baena-Diez, Jose Miguel ;
Sorribes, Marta ;
Fores, Rosa ;
Toran, Pere ;
Vicheto, Marisa ;
Pera, Guillem ;
Reina, Maria Dolores ;
Albaladejo, Carlos ;
Llussa, Judith ;
Bundo, Magda ;
Sancho, Amparo ;
Heras, Antonio ;
Rubies, Joan ;
Arenillas, Juan Francisco .
BMC PUBLIC HEALTH, 2007, 7 (1)
[2]
BAENADIEZ JM, 2009, REV ESP CARDIOL SA, V9, pA4
[3]
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease [J].
Belch, Jill ;
MacCuish, Angus ;
Campbell, Iain ;
Cobbe, Stuart ;
Taylor, Roy ;
Prescott, Robin ;
Lee, Robert ;
Bancroft, Jean ;
MacEwan, Shirley ;
Shepherd, James ;
Macfarlane, Peter ;
Morris, Andrew ;
Jung, Roland ;
Kelly, Christopher ;
Connacher, Alan ;
Peden, Norman ;
Jamieson, Andrew ;
Matthews, David ;
Leese, Graeme ;
McKnight, John ;
O'Brien, Iain ;
Semple, Colin ;
Petrie, John ;
Gordon, Derek ;
Pringle, Stuart ;
MacWalter, Ron .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 :a1840
[4]
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials [J].
Berger, Jeffrey S. ;
Krantz, Mori J. ;
Kittelson, John M. ;
Hiatt, William R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (18) :1909-1919
[5]
BOLIBAR B, 2002, TAXES INCIDENCIA PRE, P10
[6]
Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Petitti, Diana B. ;
DeWitt, Thomas G. ;
Gregory, Kimberly D. ;
Harris, Russell ;
Isham, George ;
LeFevre, Michael L. ;
Loveland-Cherry, Carol ;
Marion, Lucy N. ;
Moyer, Virginia A. ;
Ockene, Judith K. ;
Sawaya, George F. ;
Siu, Albert L. ;
Teutsch, Steven M. ;
Yawn, Barbara P. .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (07) :474-W160
[7]
Clark N, 2003, DIABETES CARE, V26, P3333
[8]
*COM ESP INT PREV, 2009, CLIN INVEST ARTERIOS, V21, P124
[9]
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[10]
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures [J].
Cook, Nancy R. ;
Ridker, Paul M. .
ANNALS OF INTERNAL MEDICINE, 2009, 150 (11) :795-W143